CD47 —a novel prognostic predicator in epithelial ovarian cancer and correlations with clinicopathological and gene mutation features
Epithelial ovarian cancer (EOC) is insensitive to immunotherapy due to its poor immunogenicity; thus, suitable biomarkers need to be identified for better prognostic stratification and individualized treatment...
Source: World Journal of Surgical Oncology - Category: Cancer & Oncology Authors: Xukai Luo, Jiahang Mo, Min Zhang, Wu Huang, Yiting Bao, Ruoyao Zou, Liangqing Yao and Lei Yuan Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Epithelial Cancer | Genetics | Immunotherapy | Ovarian Cancer | Ovaries